Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Jean Luc Teillaud"'
Autor:
Clémence Riffard, Laïla Letaïef, Safa Azar, Armanda Casrouge, Isabelle Brunet, Jean-Luc Teillaud, Marie-Caroline Dieu-Nosjean
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Tertiary lymphoid structures (TLS) are lymphoid organs present in inflammatory non-lymphoid tissues. Studies have linked TLS to favorable outcomes for patients with cancers or infectious diseases, but the mechanisms underlying their formatio
Externí odkaz:
https://doaj.org/article/c8dc9424248c4f60b04d4f05518a3b45
Autor:
Alicia Inés Bravo, Mariana Aris, Marylou Panouillot, Martina Porto, Marie-Caroline Dieu-Nosjean, Jean-Luc Teillaud, María Marcela Barrio, José Mordoh
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTissue biomarkers that aid in identifying cutaneous melanoma (CM) patients who will benefit from adjuvant immunotherapy are of crucial interest. Metastatic tumor-draining lymph nodes (mTDLN) are the first encounter site between the metast
Externí odkaz:
https://doaj.org/article/31317a4b55ec4d338dd8504276aa036a
Autor:
Juliette Rochefort, Ioannis Karagiannidis, Claude Baillou, Lisa Belin, Maude Guillot-Delost, Rodney Macedo, Aline Le Moignic, Véronique Mateo, Patrick Soussan, Isabelle Brocheriou, Jean-Luc Teillaud, Marie-Caroline Dieu-Nosjean, Chloé Bertolus, Francois Michel Lemoine, Géraldine Lescaille
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionOral Squamous Cell Carcinomas (OSCC) are mostly related to tobacco consumption eventually associated to alcohol (Smoker/Drinker patients: SD), but 25-30% of the patients have no identified risk factors (Non-Smoker/Non-Drinker patients: NS
Externí odkaz:
https://doaj.org/article/b577d8cbef2443068f02afd45e239bff
Autor:
Ana Victoria Casadesús, Beatriz María Cruz, Wilden Díaz, Miguel Ángel González, Tania Gómez, Briandy Fernández, Addys González, Nuris Ledón, Katya Sosa, Kathleen Castro, Armando López, Claudia Plasencia, Yaima Ramírez, Jean-Luc Teillaud, Calixto Hernández, Kalet León, Tays Hernández
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionThe anti-CD20 antibody rituximab (RTX) has substantially improved outcomes of patients with B-cell lymphomas, although more efficient therapies are needed for refractory or relapsing lymphomas. An approach to increase the clinical effecti
Externí odkaz:
https://doaj.org/article/27dd8b21477249bb9be6a6d8cabd48c2
Autor:
Charlotte Domblides, Juliette Rochefort, Clémence Riffard, Marylou Panouillot, Géraldine Lescaille, Jean-Luc Teillaud, Véronique Mateo, Marie-Caroline Dieu-Nosjean
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The tumor microenvironment is a complex ecosystem almost unique to each patient. Most of available therapies target tumor cells according to their molecular characteristics, angiogenesis or immune cells involved in tumor immune-surveillance. Unfortun
Externí odkaz:
https://doaj.org/article/56ee399f2cc542a08fe0712c87e4c971
Autor:
Claire Germain, Priyanka Devi-Marulkar, Samantha Knockaert, Jérôme Biton, Hélène Kaplon, Laïla Letaïef, Jérémy Goc, Agathe Seguin-Givelet, Dominique Gossot, Nicolas Girard, Pierre Validire, Marine Lefèvre, Diane Damotte, Marco Alifano, François M. Lemoine, Keith E. Steele, Jean-Luc Teillaud, Scott A. Hammond, Marie-Caroline Dieu-Nosjean
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The presence of tertiary lymphoid structures (TLS) in the tumor microenvironment is associated with better clinical outcome in many cancers. In non-small cell lung cancer (NSCLC), we have previously showed that a high density of B cells within TLS (T
Externí odkaz:
https://doaj.org/article/757b1a291fa64d989f66f304930a5ace
Autor:
Ana Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, Katya Sosa, Nathalie Josseaume, Circe Mesa, Kalet León, Tays Hernández, Jean-Luc Teillaud
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Anti-CD20 treatment represents a therapeutic benefit for patients with B-cell lymphomas, although more efficient therapies are needed for refractory or relapsing patients. Among them, the combination of anti-CD20 and IL-2 that induces T cell response
Externí odkaz:
https://doaj.org/article/3bcd9f905d40474e9def20f2e1f193b8
Autor:
Daniel Baty, Jean-Luc Teillaud, Patrick Chames, André Pèlegrin, Bruno Robert, Brigitte Kerfelec, Charlotte Boix, Ghislaine Behar, Martine Chartier, Corinne Pétiard, Amélie Cornillon, Caroline Rozan
PDF file - 60K, Lack of competition between bsFab and human IgG for FcγRIIIa binding.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cca666b6c70b795ecbb7f15043ac786
https://doi.org/10.1158/1535-7163.22499808
https://doi.org/10.1158/1535-7163.22499808
Autor:
Daniel Baty, Jean-Luc Teillaud, Patrick Chames, André Pèlegrin, Bruno Robert, Brigitte Kerfelec, Charlotte Boix, Ghislaine Behar, Martine Chartier, Corinne Pétiard, Amélie Cornillon, Caroline Rozan
PDF file - 70K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6118553ab49972b705e04f2af9747754
https://doi.org/10.1158/1535-7163.22499805.v1
https://doi.org/10.1158/1535-7163.22499805.v1
Autor:
Daniel Baty, Jean-Luc Teillaud, Patrick Chames, André Pèlegrin, Bruno Robert, Brigitte Kerfelec, Charlotte Boix, Ghislaine Behar, Martine Chartier, Corinne Pétiard, Amélie Cornillon, Caroline Rozan
PDF file - 120K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e31fd8289949aaa23fd897d10a8b32a
https://doi.org/10.1158/1535-7163.22499802
https://doi.org/10.1158/1535-7163.22499802